VBWG

Slides

Core Curriculum

Progress and Promise in RAAS Blockade

View/Download individual slides (82 Slides)

Core Curriculum

Leading the Way in Cardiovascular Regenerative Medicine

View/Download individual slides (54 Slides)

Core Curriculum

Vascular Dysfunction: Sequelae of Acute Hypertension

View/Download individual slides (84 Slides)

Core Curriculum

Myocardial Ischemia Redefined: Optimal Care in CAD

View/Download individual slides (90 Slides)

Core Curriculum

Hyperglycemia and Acute Coronary Syndromes

View/Download individual slides (84 Slides)

Core Curriculum

Contemporary Management of Cardiometabolic Risk

View/Download individual slides (105 Slides)

Core Curriculum

Advancing Our Understanding of RAAS Modulation in High-Risk Patients

View/Download individual slides (67 Slides)

ADOPT: A Diabetes Outcome Progression Trial

View/Download individual slides (15 Slides)
More slides >
 

E-Learning

Serelaxin: Breakthrough Therapy or Also-ran?

John R Teerlink MD, UCSF School of Medicine

A Novel Approach to Preventing Aortic Stenosis

Jean-Claude Tardif MD, Montreal Heart Institute

Future Pharmacological Options for Heart Failure

Christopher O'Connor MD, Duke University Medical Center

New Approaches to Modifying Risk by Improved Glycemic Management

Deepak L Bhatt MD, MPH, Harvard Medical School

PCSK9 Inhibitors and the Unmet Need for LDL-C Reduction

Evan A Stein MD, PhD, University of Cincinnati

Is Left Atrial Occlusion Really an Alternative to Lifelong Anticoagulation?

David R Holmes Jr. MD, Mayo Clinic, Rochester, MN

Direct Inhibition of Inflammation: CANTOS, CIRT, and Beyond

Paul M Ridker MD, Brigham and Women's Hospital
More e-learning >

Continuing Education

PCSK9-inhibitors Take Center Stage at ACC

Six Phase III clinical trials involving PCSK9-inhibitors will be presented at the ACC Scientific Sessions in Washington, DC. Two have been accepted for the Late-Breaking Clinical Trials Sessions, GAUSS-2 and LAPLACE-2. 
More education >

Monograph

Vascular Biology in Clinical Practice TM Vol. 7, No. 2

New Frontiers in CVD Risk Management Supporting Early Aggressive Therapy

This monograph, New Frontiers in CVD Risk Management Supporting Early Aggressive Therapy , is offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.

Vascular Biology in Clinical Practice © Vol. 7, No. 1

ACE Inhibition in CAD Patients: Expanding the Reach of Cardioprotection

This monograph, ACE Inhibition in CAD Patients: Expanding the Reach of Cardioprotection , which is being offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.

Vascular Biology in Clinical Practice © Vol. 6, No. 3

A HOPE FOR PEACE? Update on the role of ACE inhibition in CAD patients

This monograph, A HOPE for PEACE? Update on the role of ACE inhibition in CAD patients , is offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.
More monographs >